Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fortin

Showing results (291-300 of 329) with videos related to

Pageof 33
Sort By:
Annals of the Rheumatic Diseases|December 13, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortalityYann L C Becker, Éric Boilard, Emmanuelle Rollet-Labelle, et al.
Annals of the Rheumatic Diseases|April 12, 2012
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort studyJohn G Hanly, Murray B Urowitz, Li Su, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception CohortYann Nguyen, Benoît Blanchet, Murray B Urowitz, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Lupus Science & Medicine|November 17, 2022
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquineCelline C Almeida-Brasil, John G Hanly, Murray Urowitz, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortMay Yee Choi, Ann Elaine Clarke, Murray Urowitz, et al.
Annals of the Rheumatic Diseases|January 11, 2013
Lymphoma risk in systemic lupus: effects of disease activity versus treatmentSasha Bernatsky, Rosalind Ramsey-Goldman, Lawrence Joseph, et al.
Advances in Rheumatology (London, England)|April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registryElena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
Arthritis Care & Research|August 20, 2020
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and MedicationsSasha Bernatsky, Rosalind Ramsey-Goldman, Murray B Urowitz, et al.
Rheumatology (Oxford, England)|February 8, 2021
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohortChristine Chew, John A Reynolds, Apinya Lertratanakul, et al.
Pageof 33

Showing results (291-300 of 329) with videos related to

Sort By:
Pageof 33
Annals of the Rheumatic Diseases|December 13, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortalityYann L C Becker, Éric Boilard, Emmanuelle Rollet-Labelle, et al.
Annals of the Rheumatic Diseases|April 12, 2012
Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort studyJohn G Hanly, Murray B Urowitz, Li Su, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 17, 2023
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception CohortYann Nguyen, Benoît Blanchet, Murray B Urowitz, et al.
Clinical and Experimental Rheumatology|July 30, 2025
Antiphospholipid antibody-related clinical manifestations during childhood versus adulthood: descriptive results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryJheel Pandya Bhatt, Marissa Dale, Danieli Castro Oliveira de Andrade, et al.
Lupus Science & Medicine|November 17, 2022
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquineCelline C Almeida-Brasil, John G Hanly, Murray Urowitz, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception CohortMay Yee Choi, Ann Elaine Clarke, Murray Urowitz, et al.
Annals of the Rheumatic Diseases|January 11, 2013
Lymphoma risk in systemic lupus: effects of disease activity versus treatmentSasha Bernatsky, Rosalind Ramsey-Goldman, Lawrence Joseph, et al.
Advances in Rheumatology (London, England)|April 17, 2026
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registryElena Gkrouzman, Alicia Matijasevich, Carolina Bonilla Richero, et al.
Arthritis Care & Research|August 20, 2020
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and MedicationsSasha Bernatsky, Rosalind Ramsey-Goldman, Murray B Urowitz, et al.
Rheumatology (Oxford, England)|February 8, 2021
Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohortChristine Chew, John A Reynolds, Apinya Lertratanakul, et al.
Pageof 33